|
Generic Drug System, an Example of justice in health in the field of pharmaceutical services
|
| |
|
|
|
Abstract: (4109 Views) |
Abstract
Background and Purpose: Health equity and the use of generic drugs is an important tool in the field of financial resource efficiency and one of the crucial factors in the field of health economics in the world. In Iran, the approach to the development of the Iranian drug system, which occurred after the victory of the Islamic Revolution in the field of health and Its strategies for reducing drug costs were an important step in this manner.
Results: The main factors of lack of productivity in health equity in the field of pharmaceutical products, is less using generic drugs and using expensive drugs ( brand) and using non-standard drugs and counterfeit drugs and inappropriate usage of drugs. Over Last 40 years, the growing trend of prescribing generic drugs instead of branded or branded medicines has increased increase productivity and saving billions of pounds in the world and in the health system. In a study, generic drugs in the United States, Southeast Asia, and the Eastern Mediterranean are by public sector near international reference prices, but in the African, European, and Pacific regions, governments are paid average 34 to 44 percent more Which is required.
In Australia, mandatory price reductions and price disclosure have led to a drugs price reduction and ensuring that the costs will be repaid. In addition, price differences were a decisive factor for patients to accept generic drugs, since patients reject a generic successor when the cost is saved or the price difference is minimal.
In Iran, in order to increase productivity and reduce costs in the "modern pharmaceutical system of the country", the following five principles were specifically addressed 1- Use of the generic name 2- Centralized importation of drugs by government-controlled companies 3- Distribution of drugs across the whole country 4- ownership of Multinational drug factories and companies by goverment 5. Scientific introduction of generic drugs.
Conclusion: Several countries around the world have been using and encouraging generic drugs to lower costs and having more productivity in government and health insurance budgets. Iran's new drug system, a generic based design which was started gradually from 1980 and improved and progressed year by year, has had a significant impact on productivity, cost reductions and the availability of medicines for patients with a fully acceptable quality of care with paid costs and less out of pocket of patients. Therefore, it should be acknowledged that the implementation of the Iranian Drug Administration (generic based design) has a completely positive effect on the health system. |
|
| |
|
|
Full-Text [PDF 456 kb]
(1579 Downloads)
|
Type of Study: Review Article |
Subject:
Special
Received: 2019/10/12 | Accepted: 2019/10/12 | Published: 2019/10/12
|
|
|
|
|
|
|
| Add your comments about this article |
|
|
|
